Jean-Christophe May
Executive VP & Chief Commercial OfficerMr. Jean-Christophe May, PharmD, MBA, also known as JC, has been the Chief Commercial Officer and Executive Vice President of Bavarian Nordic A/S since January 01, 2020. He has been Vice President of North America Dermatology at Stiefel Laboratories, Inc. since his joining in March 2012. Since March 2008 until March 2012, Mr. May was Vice President and General Manager of GSK Puerto Rico during a highly transformational period. He began his career with GSK in France in 1995 as an HIV Product Manager and in 2001-2003 was HIV Marketing & Sales Director. He moved to London in 2003 to become Director of Commercial Strategy for Infectious Diseases Europe. From 2005 to 2008, he was Commercial Director in the Netherlands. Since February 2011, he has been Chairman of the Board of Directors of the Pharmaceutical Industry Association (PIA) of Puerto Rico. Mr. May served as Vice President and Global Vaccines Commercialization Leader at GlaxoSmithKlineGSK where he was responsible for global strategic leadership and performance of several lifesaving vaccines, including Rabipur/RabAvert and Encepur. He had served as Director in the Board of PIA since February 2010. He has experience in the pharmaceutical industry. He holds a Doctor in Pharmacy Degree from the University of Lille in France and an MBA from HEC in Paris.
Positions
- Company NameBavarian Nordic A/SStock CodeBVNRYPositionExecutive VP & Chief Commercial OfficerColleagues
- HJHenrik JuuelCFO & Executive VP
- ALAnne Louise EberhardIndependent Chair
- TSTarja StenvallPresident & CEO
- RTRussell ThirskExecutive VP & COO
- NSNicole SeroffVice President Corporate Communications
- HHHeidi HunterIndependent Vice Chairman of the Board
- HMHans Martin SmithIndependent Director
- FAFranciscus A. G. M. VerwielIndependent Director
- AGAnja GjolEmployee-Elected Member of the Board
